Literature DB >> 4026376

IgA anti-endomysial antibody detection in the serum of patients with dermatitis herpetiformis following gluten challenge.

J N Leonard, T P Chorzelski, E H Beutner, J Sulej, C E Griffiths, V J Kumar, L Fry.   

Abstract

This study reports the appearance of IgA-class anti-endomysial antibodies in the serum of 8 out of 12 patients with dermatitis herpetiformis who were challenged with gluten after a number of years of control of the rash with a strict gluten-free diet. Although there was no evidence for the antibodies having any pathogenic role in the rash of dermatitis herpetiformis, their presence may be related to the deterioration in the gluten-sensitive enteropathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026376     DOI: 10.1007/bf00509231

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  13 in total

1.  Circulating reticulin autoantibodies of IgA class in dermatitis herpetiformis.

Authors:  K Ljunghall; A Scheynius; U Forsum
Journal:  Br J Dermatol       Date:  1979-02       Impact factor: 9.302

2.  Antireticulin antibody: incidence and diagnostic significance.

Authors:  P P Seah; L Fry; E J Holborow; M A Rossiter; W F Doe; A F Magalhaes; A V Hoffbrand
Journal:  Gut       Date:  1973-04       Impact factor: 23.059

3.  Types of 'reticulin' antibodies detected in human sera by immunofluorescence.

Authors:  M Rizzetto; D Doniach
Journal:  J Clin Pathol       Date:  1973-11       Impact factor: 3.411

4.  Anti-reticulin antibodies in childhood coeliac disease.

Authors:  P P Seah; L Fry; M A Rossiter; A V Hoffbrand; E J Holborow
Journal:  Lancet       Date:  1971-09-25       Impact factor: 79.321

5.  Gluten-free diet in dermatitis herpetiformis. I. Clinical response of skin lesions in 81 patients.

Authors:  T Reunala; K Blomqvist; S Tarpila; H Halme; K Kangas
Journal:  Br J Dermatol       Date:  1977-11       Impact factor: 9.302

6.  Gluten-free diet and reintroduction of gluten in dermatitis herpetiformis.

Authors:  L Fry; R M McMinn; J D Cowan; A V Hoffbrand
Journal:  Arch Dermatol       Date:  1969-08

7.  Gluten challenge in dermatitis herpetiformis.

Authors:  J Leonard; G Haffenden; W Tucker; J Unsworth; F Swain; R McMinn; J Holborow; L Fry
Journal:  N Engl J Med       Date:  1983-04-07       Impact factor: 91.245

8.  IgA anti-gliadin antibodies in coeliac disease.

Authors:  D J Unsworth; M Kieffer; E J Holborow; R R Coombs; J A Walker-Smith
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

9.  IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.

Authors:  T P Chorzelski; E H Beutner; J Sulej; H Tchorzewska; S Jablonska; V Kumar; A Kapuscinska
Journal:  Br J Dermatol       Date:  1984-10       Impact factor: 9.302

10.  IgA antigliadin antibodies: a marker of mucosal damage in childhood coeliac disease.

Authors:  E Savilahti; M Viander; M Perkkiö; E Vainio; K Kalimo; T Reunala
Journal:  Lancet       Date:  1983-02-12       Impact factor: 79.321

View more
  4 in total

1.  Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing.

Authors:  H E Prince; G L Norman; W L Binder
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Antiendomysial antibody--useful serological indicator of dermatitis herpetiformis.

Authors:  V Kumar; E H Beutner; T P Chorzelski
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

3.  Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis.

Authors:  O Hällström
Journal:  Gut       Date:  1989-09       Impact factor: 23.059

4.  Lymphocytic duodenosis and the spectrum of celiac disease.

Authors:  Jennifer L Vande Voort; Joseph A Murray; Brian D Lahr; Carol T Van Dyke; Cynthia M Kroning; S Breanndan Moore; Tsung-Teh Wu
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.